Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
第一作者:
Hsiao-Wei,Tsao
第一单位:
Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
作者:
主题词
氨肽酶类(Aminopeptidases);动物(Animals);NK细胞凝集素样受体亚家族C(NK Cell Lectin-Like Receptor Subfamily C);小鼠(Mice);人类(Humans);组织相容性抗原Ⅰ类(Histocompatibility Antigens Class I);次要组织相容性抗原(Minor Histocompatibility Antigens);杀伤细胞, 天然(Killer Cells, Natural);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);细胞系, 肿瘤(Cell Line, Tumor);肿瘤(Neoplasms);抗原呈递(Antigen Presentation);小鼠, 基因敲除(Mice, Knockout);小鼠, 近交C57BL(Mice, Inbred C57BL)
DOI
10.1016/j.immuni.2024.10.013
PMID
39561763
发布时间
2024-12-12
- 浏览1

Immunity
2863-2878.e12页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文